Hydroxyquinoline vaginal and Vitrakvi (Larotrectinib Capsules)
Determining the interaction of Hydroxyquinoline vaginal and Vitrakvi (Larotrectinib Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydroxyquinoline topical
Brand name: Trimo-San
Synonyms: Hydroxyquinoline (vaginal)
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Vitrakvi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydroxyquinoline vaginal-Vitrakvi (Larotrectinib Oral Solution)
- Hydroxyquinoline vaginal-Vitrase
- Hydroxyquinoline vaginal-Vitrase injection
- Hydroxyquinoline vaginal-Vitravene
- Hydroxyquinoline vaginal-Vitron-C
- Hydroxyquinoline vaginal-Vituz
- Vitrakvi (Larotrectinib Capsules)-Hydroxyurea
- Vitrakvi (Larotrectinib Capsules)-Hydroxyurea Capsules 200 mg, 300 mg, 400 mg
- Vitrakvi (Larotrectinib Capsules)-Hydroxyurea Capsules 500 mg
- Vitrakvi (Larotrectinib Capsules)-Hydroxyurea Tablets
- Vitrakvi (Larotrectinib Capsules)-Hydroxyzine
- Vitrakvi (Larotrectinib Capsules)-Hydroxyzine Capsules